Human in vivo evidence of reduced astrocyte activation and neuroinflammation in patients with treatment‐resistant depression following electroconvulsive therapy
Shu‐xian Xu,
Xin‐hui Xie,
Lihua Yao
et al.
Abstract:AimThis study aimed to investigate the neuroinflammatory hypothesis of depression and the potential anti‐inflammatory effect of electroconvulsive therapy (ECT) in vivo, utilizing astrocyte‐derived extracellular vesicles (ADEVs) isolated from plasma.MethodsA total of 40 patients with treatment‐resistant depression (TRD) and 35 matched healthy controls (HCs) were recruited at baseline, and 34 TRD patients completed the post‐ECT visits. Blood samples were collected at baseline and post‐ECT. Plasma ADEVs were isol… Show more
“…176 Intriguingly, the beneficial outcome of depression therapies like electroconvulsive therapy 177 has also been linked to its anti-inflammatory markers of plasma astrocyte-derived EVs (ADEVs) in human study. 178 Thus, a definitive correlation exists between the EVs and the molecular abnormalities in depression. Further, the close link between EVs and depression also establishes it as a useful biomarker.…”
“…Moreover, microglia-specific knockout of GLS-1 in the mice model lowered miR-666-3p and miR-7115-3p in the released exosomes and reduced inflammation . Intriguingly, the beneficial outcome of depression therapies like electroconvulsive therapy has also been linked to its anti-inflammatory markers of plasma astrocyte-derived EVs (ADEVs) in human study . Thus, a definitive correlation exists between the EVs and the molecular abnormalities in depression.…”
Section: Role Of Evs In Brain Disorders: Involvement
In Pathogenesis ...mentioning
Information exchange is essential for the brain, where it communicates the physiological and pathological signals to the periphery and vice versa. Extracellular vesicles (EVs) are a heterogeneous group of membrane-bound cellular informants actively transferring informative calls to and from the brain via lipids, proteins, and nucleic acid cargos. In recent years, EVs have also been widely used to understand brain function, given their "cell-like" properties. On the one hand, the presence of neuron and astrocyte-derived EVs in biological fluids have been exploited as biomarkers to understand the mechanisms and progression of multiple neurological disorders; on the other, EVs have been used in designing targeted therapies due to their potential to cross the blood-brain-barrier (BBB). Despite the expanding literature on EVs in the context of central nervous system (CNS) physiology and related disorders, a comprehensive compilation of the existing knowledge still needs to be made available. In the current review, we provide a detailed insight into the multifaceted role of brain-derived extracellular vesicles (BDEVs) in the intricate regulation of brain physiology. Our focus extends to the significance of these EVs in a spectrum of disorders, including brain tumors, neurodegenerative conditions, neuropsychiatric diseases, autoimmune disorders, and others. Throughout the review, parallels are drawn for using EVs as biomarkers for various disorders, evaluating their utility in early detection and monitoring. Additionally, we discuss the promising prospects of utilizing EVs in targeted therapy while acknowledging the existing limitations and challenges associated with their applications in clinical scenarios. A foundational comprehension of the current state-of-the-art in EV research is essential for informing the design of future studies.
“…176 Intriguingly, the beneficial outcome of depression therapies like electroconvulsive therapy 177 has also been linked to its anti-inflammatory markers of plasma astrocyte-derived EVs (ADEVs) in human study. 178 Thus, a definitive correlation exists between the EVs and the molecular abnormalities in depression. Further, the close link between EVs and depression also establishes it as a useful biomarker.…”
“…Moreover, microglia-specific knockout of GLS-1 in the mice model lowered miR-666-3p and miR-7115-3p in the released exosomes and reduced inflammation . Intriguingly, the beneficial outcome of depression therapies like electroconvulsive therapy has also been linked to its anti-inflammatory markers of plasma astrocyte-derived EVs (ADEVs) in human study . Thus, a definitive correlation exists between the EVs and the molecular abnormalities in depression.…”
Section: Role Of Evs In Brain Disorders: Involvement
In Pathogenesis ...mentioning
Information exchange is essential for the brain, where it communicates the physiological and pathological signals to the periphery and vice versa. Extracellular vesicles (EVs) are a heterogeneous group of membrane-bound cellular informants actively transferring informative calls to and from the brain via lipids, proteins, and nucleic acid cargos. In recent years, EVs have also been widely used to understand brain function, given their "cell-like" properties. On the one hand, the presence of neuron and astrocyte-derived EVs in biological fluids have been exploited as biomarkers to understand the mechanisms and progression of multiple neurological disorders; on the other, EVs have been used in designing targeted therapies due to their potential to cross the blood-brain-barrier (BBB). Despite the expanding literature on EVs in the context of central nervous system (CNS) physiology and related disorders, a comprehensive compilation of the existing knowledge still needs to be made available. In the current review, we provide a detailed insight into the multifaceted role of brain-derived extracellular vesicles (BDEVs) in the intricate regulation of brain physiology. Our focus extends to the significance of these EVs in a spectrum of disorders, including brain tumors, neurodegenerative conditions, neuropsychiatric diseases, autoimmune disorders, and others. Throughout the review, parallels are drawn for using EVs as biomarkers for various disorders, evaluating their utility in early detection and monitoring. Additionally, we discuss the promising prospects of utilizing EVs in targeted therapy while acknowledging the existing limitations and challenges associated with their applications in clinical scenarios. A foundational comprehension of the current state-of-the-art in EV research is essential for informing the design of future studies.
“…Similar to our previous ADEV studies 47,52 , the TEM was used to get the image of EVs. Twenty μl of the EV sample was added dropwise to 200-mesh grids and incubated at RT for 10 minutes, then the grids were negatively stained with 2% phosphotungstic acid for 3 minutes, and the remaining liquid was removed by filter paper.…”
Section: Methodsmentioning
confidence: 99%
“…Generally, in this protocol, we first concentrated the urine samples and isolated the uTEVs using ultracentrifugation (UC), followed by the isolation of uADEVs using biotin-anti-GLAST-antibody, similar to the isolation of ADEVs from plasma or serum [40][41][42][43][44][45][46][47]49 .…”
The identification of particularly individual-level biomarkers, for certain central nervous system (CNS) diseases remains challenging. A recent approach involving the enrichment of brain-derived extracellular vesicles (BDEVs) from peripheral blood has emerged as a promising method to obtain direct in vivo CNS data, bypassing the blood-brain barrier. However, for rapidly evolving CNS diseases (e.g., weeks or even days), the Nyquist-Shannon sampling theorem dictates the need for a high-frequency sampling rate. Obviously, daily collection of blood or cerebrospinal fluid from human subjects is impractical. Thus, we innovated a novel method to isolate astrocyte-derived EVs from urine (uADEVs). It involves three main steps: 1) concentrating urine samples, 2) isolating total EVs from urine (uTEVs) using ultracentrifugation, and 3) using an anti-glutamate/aspartate transporter (GLAST) antibody to isolate GLAST+EVs from uTEVs. Subsequently, we confirmed the identity of these GLAST+EVs as uADEVs using transmission electron microscopy, nanoparticle tracking analysis, western blotting, and the measurement of astrocyte-related neurotrophins. Furthermore, we applied the uADEVs protocol to depict the detailed trajectory of the N-methyl-d-aspartic acid receptor (NMDAR) subunit zeta-1 (GluN1) in an anti-NMDAR encephalitis patient, demonstrated the potential of this method for capturing intricate trajectories of CNS-specific molecular in vivo signals at the individual level. This non-invasive approach enables frequent sampling, up to daily or even half-daily, analogous to capturing molecular "movies" of the brain, coupled with appropriate signal processing algorithms, holds promise for identifying novel biomarkers or illuminating the etiology of rapidly evolving CNS diseases by tracking the precise trajectories of target molecules.
“…During the neuroinflammation of the telencephalon, astrocytes become activated, identifiable by specific biomarkers such as GFAP, S100β, and CD81 [49,214]. The functionality of astrocytes is intricately linked to that of microglia, with various proinflammatory and anti-inflammatory cytokines and chemokines serving as crucial mediators of their interaction.…”
Central neurological disorders are significant contributors to morbidity, mortality, and long-term disability globally in modern society. These encompass neurodegenerative diseases, ischemic brain diseases, traumatic brain injury, epilepsy, depression, and more. The involved pathogenesis is notably intricate and diverse. Ferroptosis and neuroinflammation play pivotal roles in elucidating the causes of cognitive impairment stemming from these diseases. Given the concurrent occurrence of ferroptosis and neuroinflammation due to metabolic shifts such as iron and ROS, as well as their critical roles in central nervous disorders, the investigation into the co-regulatory mechanism of ferroptosis and neuroinflammation has emerged as a prominent area of research. This paper delves into the mechanisms of ferroptosis and neuroinflammation in central nervous disorders, along with their interrelationship. It specifically emphasizes the core molecules within the shared pathways governing ferroptosis and neuroinflammation, including SIRT1, Nrf2, NF-κB, Cox-2, iNOS/NO·, and how different immune cells and structures contribute to cognitive dysfunction through these mechanisms. Researchers’ findings suggest that ferroptosis and neuroinflammation mutually promote each other and may represent key factors in the progression of central neurological disorders. A deeper comprehension of the common pathway between cellular ferroptosis and neuroinflammation holds promise for improving symptoms and prognosis related to central neurological disorders.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.